Ju Fu Tang Biotech Holdings Co., Ltd logo

Ju Fu Tang Biotech Holdings Co., Ltd

8217.HK

HKSEIndustrialsEngineering & Construction

Latest quote

HK$0.102

−HK$0.005 · -4.67%

Aug 24, 4:08 PM HKT

8217.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

"As an investment holding company, Ju Fu Tang Biotech Holdings Co., Ltd primarily delivers a comprehensive range of civil engineering, decoration, and renovation services across Hong Kong. Its extensive portfolio covers infrastructure development, specifically road and drainage systems. This encompasses the building and enhancement of local roads and carriageway junctions, along with related facilities such as footpaths, planting zones, drainage networks, sewer lines, water mains, and utility relocation solutions. Additionally, the company undertakes foundational structural projects, including the erection of reinforced concrete structures for bridges and retaining walls. Furthermore, their expertise extends to site preparation, involving excavation and filling operations essential for new site development or future construction. The entity previously operated under the name WMHW Holdings Limited before rebranding as Ju Fu Tang Biotech Holdings Co., Ltd in September 2025. Established in 2015, the firm maintains its headquarters in Causeway Bay, Hong Kong."

Industry
Engineering & Construction
Sector
Industrials
Headquarters
HK
CEO
Chun Zhi Cai
Listed since
Apr 12, 2016
Employees
23

Market position

Day range

Current HK$0.102

52-week range

Current HK$0.102

Open
HK$0.109
Previous close
HK$0.107
Volume
1.09M
1.14× average
Average volume
960.98K
Average daily volume
Market cap
30.79M HKD
Beta
0.63
Market reference 1
50-day average
HK$0.1129
-9.65% below average
200-day average
HK$0.2627
-61.18% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
1.32×
P/B (TTM)
0.61×
P/S (TTM)
0.82×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
2.71%
Operating margin
-16.41%
Net margin
62.09%

Financial health

Debt / equity
0.24×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends73%29%-16%-61%Gross margin, FY2021: 1.12%Gross margin, FY2022: -2.75%Gross margin, FY2023: 5.35%Gross margin, FY2024: 2.71%Gross margin, FY2025: 2.71%Operating margin, FY2021: -21.00%Operating margin, FY2022: -8.84%Operating margin, FY2023: -47.56%Operating margin, FY2024: -14.31%Operating margin, FY2025: -16.41%Net margin, FY2021: -21.72%Net margin, FY2022: -9.52%Net margin, FY2023: -49.61%Net margin, FY2024: -16.29%Net margin, FY2025: 62.09%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 1.12%. Gross margin FY2022 -2.75%. Gross margin FY2023 5.35%. Gross margin FY2024 2.71%. Gross margin FY2025 2.71%. Operating margin FY2021 -21.00%. Operating margin FY2022 -8.84%. Operating margin FY2023 -47.56%. Operating margin FY2024 -14.31%. Operating margin FY2025 -16.41%. Net margin FY2021 -21.72%. Net margin FY2022 -9.52%. Net margin FY2023 -49.61%. Net margin FY2024 -16.29%. Net margin FY2025 62.09%.

Income trends

Revenue

37.56M HKD+3.74%

Operating income

−6.16M HKD-19.02%

Net income

23.32M HKD+29.22M HKD
Income trends across reported periods117.08M HKD67.18M HKD17.28M HKD−32.62M HKDRevenue, FY2021: 92.75M HKDRevenue, FY2022: 104.6M HKDRevenue, FY2023: 35.14M HKDRevenue, FY2024: 36.2M HKDRevenue, FY2025: 37.56M HKDOperating income, FY2021: −19.48M HKDOperating income, FY2022: −9.24M HKDOperating income, FY2023: −16.71M HKDOperating income, FY2024: −5.18M HKDOperating income, FY2025: −6.16M HKDNet income, FY2021: −20.15M HKDNet income, FY2022: −9.96M HKDNet income, FY2023: −17.43M HKDNet income, FY2024: −5.9M HKDNet income, FY2025: 23.32M HKDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 92.75M HKD. Revenue FY2022 104.6M HKD. Revenue FY2023 35.14M HKD. Revenue FY2024 36.2M HKD. Revenue FY2025 37.56M HKD. Operating income FY2021 −19.48M HKD. Operating income FY2022 −9.24M HKD. Operating income FY2023 −16.71M HKD. Operating income FY2024 −5.18M HKD. Operating income FY2025 −6.16M HKD. Net income FY2021 −20.15M HKD. Net income FY2022 −9.96M HKD. Net income FY2023 −17.43M HKD. Net income FY2024 −5.9M HKD. Net income FY2025 23.32M HKD.
Metric (HKD)FY2025FY2024FY2023FY2022FY2021
Revenue37.56M HKD36.2M HKD35.14M HKD104.6M HKD92.75M HKD
Cost of goods sold36.54M HKD35.22M HKD33.26M HKD107.48M HKD91.71M HKD
Gross profit1.02M HKD982K HKD1.88M HKD−2.88M HKD1.04M HKD
Selling, general, and administrative7.18M HKD13.11M HKD7.57M HKD9.82M HKD10.63M HKD
Operating expenses7.18M HKD6.16M HKD18.59M HKD6.36M HKD20.52M HKD
Interest expense720K HKD720K HKD720K HKD721K HKD733K HKD
Depreciation and amortization40K HKD80K HKD80K HKD113K HKD339K HKD
Operating income−6.16M HKD−5.18M HKD−16.71M HKD−9.24M HKD−19.48M HKD
Net income23.32M HKD−5.9M HKD−17.43M HKD−9.96M HKD−20.15M HKD

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.07

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.110.05-0.01-0.07Q4 '23Q1 '24Q2 '24Q2 '24Q4 '24Q1 '25Q1 '25Q3 '25
Q4 2023, reported Nov 15, 2023: actual -0.032, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 15, 2024: actual 0.004, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 27, 2024: actual 0.004, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 30, 2024: actual -0.008, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 29, 2024: actual -0.008, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual -0.002, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual -0.004, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual 0.069, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates18.29M13.64M8.99M4.34MQ4 '23Q1 '24Q2 '24Q2 '24Q4 '24Q1 '25Q1 '25Q3 '25
Q4 2023, reported Nov 15, 2023: actual 7.88M HKD, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Feb 15, 2024: actual 7.3M HKD, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 27, 2024: actual 7.3M HKD, estimate —, surprise —, Comparison unavailable. Q2 2024, reported Jun 30, 2024: actual 13M HKD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Nov 29, 2024: actual 13M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 14, 2025: actual 5.1M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 31, 2025: actual 10.2M HKD, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Sep 30, 2025: actual 17.31M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Corporate action history

Stock split

Effective Sep 13, 2021

1:4

Stock split

Effective Mar 18, 2020

1:4

8217.HK peers

Continue in GoAI

Research 8217.HK

research.disclaimer